Oculomotor Function Testing in Acute Concussion

NCT ID: NCT03892356

Last Updated: 2019-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-03-01

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective longitudinal study which aims to compare oculomotor function and visual scanning behaviour (VSB) of participants who suffered concussion with healthy controls with no concussion. This study also aims to investigate the pattern of change in oculomotor function and visual scanning behaviour (VSB) in the participants over a 6-month period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objective

* To identify differences in oculomotor function and visual scanning behaviour (VSB) between participant with and without acute concussion
* To investigate patterns of change and recovery in oculomotor function and VSB in participants who suffered a concussion

Secondary Objective

• To investigate the association between the oculomotor function and concussion-related symptoms

This is a prospective longitudinal study which aims to evaluate differences in oculomotor function and visual scanning behaviour (VSB) between participants who suffered acute concussion and healthy controls with no concussion. This study also aims to investigate the pattern of change in oculomotor function and visual scanning behaviour (VSB) in the participants over a 6-month period.

Health information and concussion history: After obtaining informed consents, during the first visit, participants will be asked about their health history such as past medical history, medication history, substance use history, and family history. They will also be asked about their concussion history which includes number of concussions in the past, any comorbidity with the concussions, mechanism of injury, and any change in their levels of consciousness at the time of concussion.

Self-reported outcomes: During each visit, participants will be asked on the presence or absence of concussion-related symptoms and the extent to which these symptoms affect their everyday functioning if present. The symptoms the participants will be questioned using the Rivermead Post-concussive Symptom Questionnaire (RPQ) as a standardized assessment (https://www.commondataelements.ninds.nih.gov/TBI.aspx#tab=Data\_Standards) at each visit .

Oculomotor function testing and visual scanning behaviour (VSB): During each visit, oculomotor data will be collected using Visual Attention Scanning Technology (VAST, EL-MAR Inc.). VAST is a technology that was developed to support advanced eye-tracking research application. Over the past 10 years the technology has been used in research studies in the University of Toronto, and University Health Network hospitals. Participants will be seated 65 cm from the monitor, and their binocular gaze positions will be estimated 30 times/sec with an accuracy of 0.5º in visual angle. Following a calibration procedure, the participants will be instructed to look at a series of slides presented on the monitor, and their eye positions will be recorded. The eye positions will be segmented into fixations that are linked to the displayed images. Oculomotor functions testing includes testing self-paced saccadic (SPS) eye movements, fixation, anti-saccadic eye movements. Visual scanning behaviour (VSB) will be assessed using a set of images which require patients to look at the images and match them according to the instruction at the beginning of each test.

Patients will be assessed at baseline (i.e. within 7 days of concussion) and three follow-up (f/u) visits (i.e. 1, 3, and 6 months after concussion).

Healthy controls will be assessed at baseline and one follow-up visit (i.e. 6 months after the baseline).

The entire assessment in each visit takes 30-45 minutes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Concussion, Brain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Concussion Group

Participants (age group 18-60) who presents to the emergency department in the University Health Network within 7 days of concussion

No interventions assigned to this group

Healthy Controls Group

Participants (age group 18-60) with no previous history of concussions who are age, education and sex-matched to the patients' group will be recruited from the community.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Participants (age group 18-60) who present to the emergency department in the University Health Network within 7 days of concussion


• Participants (age group 18-60) with no previous history of concussions who are age, education and sex-matched to the patients' group will be recruited from the community.

Exclusion Criteria

* Age less than 18
* Any other neurological disorder (e.g. seizures)
* Any systemic illness known to affect the brain (e.g. diabetes and lupus)
* History of major psychiatric disorder (e.g. bipolar, schizophrenia)
* History of known developmental disorders (e.g. attention deficit disorder, dyslexia)
* Any lesion detected by MRI prior to the study
* Any previous vision disorder that prevents the participant from performing the self-paced saccade task
* Any brain injury more severe than concussion

Controls:

• Participants (age group 18-60) with no previous history of concussions who are age, education and sex-matched to the patients' group will be recruited from the community.

Healthy Controls:
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Health Network, Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carmela Tartaglia

Marion and Gerald Soloway Chair in Brain Injury and Concussion Research Associate Professor, University of Toronto

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Canadian Concussion Centre, Toronto Western Hospital, University Health Network

Toronto, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mozhgan Khodadadi, MA

Role: CONTACT

416-603-5800 ext. 4025

Carmela Tartaglia, M.D.

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mozhgan Khodadadi, MA

Role: primary

416-603-5800 ext. 4025

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18-6196

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Biofeedback Training for Hemianopia
NCT06995313 RECRUITING NA
Visual Attention and Eye Movements
NCT03298737 ENROLLING_BY_INVITATION
Spectacles Lens in Concussed Kids
NCT03123822 TERMINATED NA